Your browser doesn't support javascript.
loading
Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19.
Wick, Katherine D; Leligdowicz, Aleksandra; Willmore, Andrew; Carrillo, Sidney A; Ghale, Rajani; Jauregui, Alejandra; Chak, Suzanna S; Nguyen, Viet; Lee, Deanna; Jones, Chayse; Dewar, Robin; Lane, H Clifford; Kangelaris, Kirsten N; Hendrickson, Carolyn M; Liu, Kathleen D; Sinha, Pratik; Erle, David J; Langelier, Charles R; Krummell, Matthew F; Woodruff, Prescott G; Calfee, Carolyn S; Matthay, Michael A.
Afiliação
  • Wick KD; Cardiovascular Research Institute, University of California San Francisco, 503 Parnassus Ave, HSE 760, San Francisco, CA, 94143, USA. kdwick@ucdavis.edu.
  • Leligdowicz A; Cardiovascular Research Institute, University of California San Francisco, 503 Parnassus Ave, HSE 760, San Francisco, CA, 94143, USA.
  • Willmore A; Division of Critical Care, Departments of Medicine and Microbiology and Immunology, Western University, London, ON, Canada.
  • Carrillo SA; Robarts Research Institute, Western University, London, ON, Canada.
  • Ghale R; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Jauregui A; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Chak SS; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Nguyen V; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Lee D; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Jones C; Cardiovascular Research Institute, University of California San Francisco, 503 Parnassus Ave, HSE 760, San Francisco, CA, 94143, USA.
  • Dewar R; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, USA.
  • Lane HC; Cardiovascular Research Institute, University of California San Francisco, 503 Parnassus Ave, HSE 760, San Francisco, CA, 94143, USA.
  • Kangelaris KN; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, USA.
  • Hendrickson CM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Liu KD; Virus Isolation and Serology Laboratory, Applied and Developmental Directorate, Frederick National Laboratory, Frederick, MD, USA.
  • Sinha P; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Erle DJ; Department of Hospital Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Langelier CR; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, USA.
  • Krummell MF; Division of Nephrology, Department of Medicine, University of California San Francisco School of Medicine, San Francisco, CA, USA.
  • Woodruff PG; Division of Critical Care Medicine, Department of Anesthesia, University of California San Francisco School of Medicine, San Francisco, CA, USA.
  • Calfee CS; Department of Anesthesia, Division of Critical Care, Washington University, St. Louis, MO, USA.
  • Matthay MA; Division of Clinical and Translational Research, Washington University School of Medicine, St. Louis, MO, USA.
Crit Care ; 26(1): 278, 2022 09 14.
Article em En | MEDLINE | ID: mdl-36104754

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Crit Care Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Crit Care Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos